Bio

Dr. Vishwanatha Reddy obtained a Bachelor’s in Veterinary Medicine (DVM equivalent) in 2007 and a Master of Veterinary Science in Biochemistry in 2010 from India. Subsequently, he obtained a PhD in Poultry Virology at Ghent University, Belgium, and in 2016, joined the Pirbright Institute, United Kingdom (UK), as a Postdoctoral Scientist to further his research on the vaccinology and
immunopathogenesis of poultry viruses. Since 2023, he has been working as an independent Principal Investigator in Poultry Virology.

Dr. Reddy has over 14 years of experience working on important poultry viruses, such as infectious bronchitis virus (IBV; avian coronavirus), infectious laryngotracheitis virus (ILTV; avian herpesvirus), infectious bursal disease virus (IBDV; avian birnavirus), avian metapneumovirus (aMPV), and avian influenza virus (AIV; orthomyxovirus).

Area(s) of Expertise

Dr. Reddy’s research integrates in vitro, ex vivo, and in vivo approaches with novel molecular virology tools, such as the reverse genetics system and CRISPR/Cas9, to elucidate the molecular basis of viral pathogenesis mechanisms to improve vaccine design and vaccination strategies. Additionally, Dr. Reddy applies next-generation sequencing techniques, novel RTqPCR assays, and reverse genetics-based neutralization assays to innovate diagnostics and/or genotype circulating viruses; viral load quantification to dissect the potential spread and transmission routes; and evaluation of the antigenicity-relatedness of diverse field genotype viral strains.

Dr. Reddy’s long-term research interests are in poultry virology to "strategically design vaccines and vaccination strategies and innovate diagnostics by understanding viral invasion mechanisms and pathogenicity and/or antigenicity determinants."